Company intelligence / Profile preview

Tetra Bio-Pharma Inc.

Orleans, Ontario, Canadatetrabiopharma.com ↗

Ownership: Private
Employees: ~33
Development stage: Phase 2

Overview

The company had several clinical programs including REBORN1 Phase 2 trial evaluating QIXLEEF against morphine for cancer pain, and was developing various cannabinoid-derived products for multiple indications

Therapeutic areas: PulmonologyOphthalmologyImmunologyOncologyNeurologyInfectious Diseases
Modalities: Cannabinoid-derived drugs
Industry: Biotech

Drug pipeline

9 assets

Caumz

8 more assets in the full pipeline.

Request access →

Partnerships

AvicannaIntelGenx CorpAphriaCellvera Global Holdings LLC

Beyond the preview

Go deeper on Tetra Bio-Pharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetra Bio-Pharma Inc..

Explore the full profile